Showing 1121-1130 of 21420 results for "".
- Neuro-Ophthalmic Toxicity from Immune Checkpoint Inhibitorshttps://reachmd.com/news/neuro-ophthalmic-toxicity-from-immune-checkpoint-inhibitors/2488092/Key Takeaways Food and Drug Administration Adverse Event Reporting System reports of ICI-associated neuro-ophthalmic irAEs were more often submitted for males and for adults aged 65 years or older. Pembrolizumab and avelumab were the only ICIs to meet HLGT-level crit
- GPT-4 in Psychosis Psychoeducation: Strong Scores, Lower Inclusivityhttps://reachmd.com/news/gpt-4-in-psychosis-psychoeducation-strong-scores-lower-inclusivity/2488087/Key Takeaways In a first-episode psychosis program, GPT-4 responses to common psychoeducation questions from patients, caregivers, and relatives were generally rated strongly across the main quality domains. Inclusivity was the relative weak point, suggesting less co
- TyG-WHtR Predicts Incident Aortic Stenosis in UK Biobankhttps://reachmd.com/news/tyg-whtr-incident-aortic-stenosis-uk-biobank/2488083/Key Takeaways Adults in UK Biobank with CKM stages 0–3 were followed prospectively, and higher TyG and obesity-derived TyG indices were associated with later aortic stenosis. Participants in the highest tertile of each TyG-related index had greater aortic stenosis ri
- TTSS Helps Triage Isolated Thoracic Trauma to ICU Carehttps://reachmd.com/news/ttss-helps-triage-isolated-thoracic-trauma-to-icu-care/2488069/Key Takeaways Among 100 adults with isolated thoracic trauma treated at two tertiary referral centers in Muscat, Oman, the Thorax Trauma Severity Score (TTSS) showed significant discrimination for ICU admission. Higher TTSS was significantly correlated with longer IC
- Nevus-Associated Melanoma: Dermoscopy and Invasivenesshttps://reachmd.com/news/nevus-associated-melanoma-dermoscopy-invasiveness/2488059/Key Takeaways In a single-center Italian cohort of histologically confirmed NAM, the nevus component was dermoscopically visible in 45.6% of lesions, and invasive tumors were more common than in situ tumors. A dermoscopically visible nevus component was independently
- Maternal Assault Linked to Higher Child Injury Risk in Ontariohttps://reachmd.com/news/maternal-assault-linked-to-higher-child-injury-risk-in-ontario/2488049/Key Takeaways In Ontario, children whose mothers had assault-related injuries severe enough to result in emergency care, hospitalization, or death had higher 5-year assault-related injury risk than matched unexposed children, 3.7% versus 1.3%. These children also had
- Fish Oil With Low-Dose Isotretinoin Shows Noninferior Acne Controlhttps://reachmd.com/news/fish-oil-with-low-dose-isotretinoin-shows-noninferior-acne-control/2488054/Fish oil supplementation added to low-dose isotretinoin was noninferior to isotretinoin alone for reducing acne lesions and may help preserve skin hydration and limit increases in triglyceride levels, according to findings published in the
- IL-6Ri vs csIM in Polymyalgia Rheumaticahttps://reachmd.com/news/il-6ri-csim-polymyalgia-rheumatica/2488038/Key Takeaways Among older adults with PMR in matched US Medicare claims cohorts, IL-6Ri initiation was associated with significantly more year-1 GC discontinuation than csIM initiation. Minimal GC use, defined as prednisone-equivalent dosing of 2 mg/day or less or st
- MICA-129 Val/Val Linked to Poorer IPF Survival on Nintedanibhttps://reachmd.com/news/mica-129-valval-ipf-survival-nintedanib/2488039/Key Takeaways In a Sardinian IPF cohort, poorer 48-month survival was observed among nintedanib-treated patients with the MICA-129 Val/Val genotype. The mortality association in the nintedanib subgroup persisted after adjusted and weighted analyses. No signi
- Organon Launches Sci-Fi Inspired Campaign to Spotlight VTAMA's First-in-Class Sciencehttps://reachmd.com/news/organon-launches-sci-fi-inspired-campaign-to-spotlight-vtamas-first-in-class-science/2488034/Organon is launching a new multi-channel creative campaign for VTAMA (tapinarof) cream, 1% that draws on science fiction and space-inspired storytelling to engage dermatology clinicians and emphasize the product's novel mechanism of action. Built around the tagline, "It's not science ficti